TY - CHAP M1 - Book, Section TI - Chapter 178. Non-Necrotizing Infections of the Dermis and Subcutaneous Fat: Cellulitis and Erysipelas A1 - Lipworth, Adam D. A1 - Saavedra, Arturo P. A1 - Weinberg, Arnold N. A1 - Johnson, Richard Allen A2 - Goldsmith, Lowell A. A2 - Katz, Stephen I. A2 - Gilchrest, Barbara A. A2 - Paller, Amy S. A2 - Leffell, David J. A2 - Wolff, Klaus PY - 2012 T2 - Fitzpatrick's Dermatology in General Medicine, 8e AB - |PrintNon-Necrotizing Infections of the Dermis and Subcutaneous Tissue at a GlanceApproximately 7%–10% of hospitalizations in North America are due to skin and soft-tissue infections (SSTI), including cellulitis and erysipelas.The incidence of SSTI is increasing, paralleling the rise of methicillin-resistant Staphylococcus aureus.A high index of suspicion for resistant organisms shoamaintained for cases that do not improve rapidly with empiric therapy, or in areas where resistant strains have been reported.Newer antibiotics are currently available or undergoing testing to treat resistant infections caused by methicillin-resistant or vancomycin-resistant strains.Microbiologic data from various culture techniques is helpful, but swabs, aspirations, and tissue cultures generally have a low yield for uncomplicated cellulitis and erysipelas.Non-necrotizing soft-tissue infections are treated with antibiotics and supportive measures, with drainage of collections as needed. SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/03/29 UR - accessmedicine.mhmedical.com/content.aspx?aid=56082056 ER -